Evans John M. bought BEAM
June 30, 2026 · Form 4 insider transaction
Evans John M. bought 25,000 shares of Beam Therapeutics Inc. at $1.03 per share, a transaction worth $25.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$1.03
Total value
$25.8K
InsiderEvans John M.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 30, 2026
Filing dateJuly 1, 2026
Shares owned after1,072,205
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.